Alcon Inc. ALC gains on strong market share gains. The company’s broad pipeline and focus on research and innovation are impressive. Yet, a challenging international market with geopolitical ...

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments ...

The webcast can be accessed online through Alcon's Investor Relations website, i.e. investor.alcon.com. Listeners should log on approximately 10 minutes in advance. A replay will be available ...

Alcon Research LLC is trying to engineer a cheap acquisition of Aurion Biotech Inc. by blocking Aurion’s other funding options and improperly gaining influence on its board, Aurion investors claim in ...

This is a paint.net filetype plugin for loading SVG (Scalable Vector Graphics) and its compressed variant SVGZ files. SVG files can be rendered as a flat image or each element/group on a separate ...

As Alcon Research seeks to block investee Aurion Biotech from listing on the New York Stock Exchange, another investor has come to Aurion’s defense. Deerfield Management has sued Alcon Research ...

Voyager Direct Selective Laser Trabeculoplasty (DSLT) will be launched at the American Glaucoma Society annual meeting in Washington, D.C. "I have been using Voyager DSLT since October of 2024 ...

The device is available in select markets, broadening access to first-line SLT therapy and expanding Alcon's glaucoma treatment portfolio. The new first-line laser treatment for glaucoma and ocular ...

3 “Alcon is dedicated to developing treatments and technologies for people living with glaucoma,” said Terry Kim, MD, Chief Medical Officer and Head of Global Medical Safety, Alcon. “By introducing ...